Bioasis Technologies (BTI.V) announced they are entering into a research collaboration with Oxyrane UK. As Equity Guru previously reported, Bioasis is developing the xB³ platform, which aims penetrate the…
Pharmaceuticals
Medexus Pharmaceuticals (MDP.T) received Health Canada’s Notice of Compliance to commercialize treosulfan today, according to a press release. Treosulfan will be sold in Canada using the brand name…
Bioasis Technologies (BTI.V) entered into a convertible security financing earlier this week with New-York based investment management firm, Lind Global Macro Fund, a subsidiary of The Lind Partners, according…
Valeo Pharma (VPH.C) announced that they have begun commercialization of their Enerzair Breezhaler and Atectura Breezhaler following the shipment of the product across Canada and the deployment of their…
Tetra Bio-Pharma (TBP.T) announced that their new investigation new drug (IND) ARDS-003 has been studied in a viral infected organoid model as part of a research collaboration between Targeted Pharmaceuticals…
Enochian BioSciences (ENOB.Q) announced today that the Company has acquired an exclusive license for an innovative technology to potentially treat and prevent all variants of coronavirus, including the cause…
Mind Cure Health (MCUR.C) announced the development of two proprietary ketamine-enhanced protocols specifically for pain management and another for depression, according to a press release. Depression is basically…
PhaseBio Pharmaceuticals (PHAS.Q), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary disease, announced today that it has entered into an exclusive licensing…
Red Light Holland (TRIP.C) and Australian-based cannabis producer, Creso Pharma (COPHF.OTCQB), agreed to combine businesses today to create combined psychedelics and cannabinoid company called The HighBrid Lab, according to…
Medexus Pharmaceuticals (MDP.V) announced that they’re making their Triamcinolone Hexacetonide (TH) Injectable Suspension, USP (20 mg/ml) available in the United States through the FDA’s CDER Drug Shortage program in…